Application no. and date | 13802815.4 (espacenet) (Federated) (European Patent Register), 20131126 | Patent/reg. no. and date | DK/EP 2925366, 20180221 | Publication date | 20151007 | Priority no. and date | US 201261731174 P, 20121129, US 201261731555 P, 20121130, US 201361755520 P, 20130123 | EP pub. no. and date |
EP 2925366 20151007 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | YOU P107452EPGAD | Inventor | PORTER, Dale, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US, EMERY, Caroline, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US, TAN, Lujian, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US, YERRAMILLI-RAO, Padmaja, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/517 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | Title | FARMACEUTISKE KOMBINATIONER | Int. application no. | US2013071852 | Int. publication no. | WO2014085381 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|